{"head":{"slug":"merck-co-inc","name":"Merck & Company Inc","symbol":"MRK","sector":"Healthcare","overallScore":5.5,"overallClassification":"HOLD","displayName":"Merck & Company Inc"},"scores":[{"classification":"BUY","strategyName":"GARP Ausgewogen","strategySlug":"garp-ausgewogen"},{"classification":"BUY","strategyName":"Dividenden-Qualität: 4 Faktoren","strategySlug":"dividenden-qualitaet"},{"classification":"BUY","strategyName":"Mohanram G-Score: Wachstums-Qualität","strategySlug":"wachstums-qualitaet-g-score"},{"classification":"HOLD","strategyName":"StockScorer-Score","strategySlug":"stockscorer-score"},{"classification":"BUY","strategyName":"Burggraben-Qualität","strategySlug":"burggraben-qualitaet"},{"classification":"HOLD","strategyName":"Wachstums-Momentum (CAN-SLIM-Prinzip)","strategySlug":"wachstums-momentum"}],"radar":{"categories":["profitability","growth","valuation","momentum"],"median":[33.3,0,0,0],"values":[100,0,0,100]},"peers":[{"classification":"HOLD","displayName":"Amgen Inc","locked":false,"name":"Amgen Inc","overallScore":5.5,"slug":"amgen-inc","symbol":"AMGN"},{"classification":"BUY","displayName":"Gilead Sciences Inc","locked":false,"name":"Gilead Sciences Inc","overallScore":8.2,"slug":"gilead-sciences-inc","symbol":"GILD"},{"classification":"HOLD","displayName":"AbbVie Inc","locked":false,"name":"AbbVie Inc","overallScore":5.5,"slug":"abbvie-inc","symbol":"ABBV"},{"classification":null,"displayName":"Pfizer Inc","locked":true,"name":"Pfizer Inc","overallScore":null,"slug":"pfizer-inc","symbol":"PFE"},{"classification":null,"displayName":"Bristol-Myers Squibb Company","locked":true,"name":"Bristol-Myers Squibb Company","overallScore":null,"slug":"bristol-myers-squibb-company","symbol":"BMY"}],"metrics":{"current_ratio":1.5362022099057437,"dividend_growth":5.128205128205132,"dividend_payout_ratio":46.695518790402105,"dividend_streak_years":21,"dividend_yield":2.3171812172016626,"dte":0.9606128578489146,"earnings_growth_3y":8.429515633293082,"equity_ratio":38.43613461341751,"ev_ebit":17.065807775994863,"fcf_margin":19.037057573237224,"fcf_yield":3.387799785103739,"kbv":6.992588488005171,"kgv":20.151863153281475,"one_yr":61.44744711475716,"peg":0.9494091901259609,"revenue_growth":1.1812741553422157,"roc_greenblatt":55.90307531181568,"roe":34.69946393947458},"quote":{"currency":"USD","exchange":"NYSE","marketCap":364838561427.0153,"marketCapEur":327406123775.66205,"price":146.73,"priceAsOf":"2026-11-06"},"sectorMedians":{"current_ratio":1.5836203666775437,"dividend_growth":5.623306233062331,"dividend_payout_ratio":35.91314413087717,"dividend_streak_years":10,"dividend_yield":1.3483331598261532,"dte":0.4838372886800787,"earnings_growth_3y":5.440658922332009,"equity_ratio":48.4008953898299,"ev_ebit":21.726364951966808,"fcf_margin":14.117834756719867,"fcf_yield":3.629326385869834,"kbv":4.751254808572999,"kgv":29.969658033759437,"one_yr":8.663206112670974,"peg":1.5047753142982023,"revenue_growth":8.039862019201006,"roc_greenblatt":32.54750002450021,"roe":11.52412853150564},"sectorPercentiles":{"current_ratio":47,"dividend_growth":48,"dividend_payout_ratio":62,"dividend_streak_years":null,"dividend_yield":77,"dte":77,"earnings_growth_3y":56,"equity_ratio":28,"ev_ebit":29,"fcf_margin":67,"fcf_yield":44,"kbv":70,"kgv":22,"one_yr":92,"peg":39,"revenue_growth":16,"roc_greenblatt":74,"roe":88},"sectorProfile":{"radar":{"categories":["profitability","growth","valuation","momentum","quality","risk"],"median":[50,50,50,50,50,50],"values":[78.9,58.8,56.9,69.8,61.5,38.9]},"sectorRank":60.8,"strongest":"profitability","weakest":"risk"},"flagshipRules":[{"id":"ss-31","knockout":false,"points":2,"status":"unmet"},{"id":"ss-32","knockout":false,"points":2,"status":"met"},{"id":"ss-33","knockout":false,"points":1,"status":"met"},{"id":"ss-34","knockout":false,"points":2,"status":"met"},{"id":"ss-27","knockout":false,"points":2,"status":"unmet"},{"id":"ss-28","knockout":false,"points":1,"status":"unmet"},{"id":"ss-29","knockout":false,"points":1,"status":"met"},{"id":"ss-30","knockout":false,"points":0,"status":"unmet"}],"strategyLockedNames":[{"strategyName":"Piotroski F-Score (9-Punkte-Bilanzcheck)","strategySlug":"finanzielle-gesundheit"},{"strategyName":"Altman Z-Score: Bilanz-Stresstest","strategySlug":"bilanz-stresstest-z-score"},{"strategyName":"Ertragsqualität: Accrual-Check (Sloan)","strategySlug":"ertragsqualitaet-accrual-check"},{"strategyName":"Levermann-Strategie (13 Kriterien)","strategySlug":"13-kriterien-punktesystem"},{"strategyName":"Trending Value: Value + Momentum","strategySlug":"value-momentum"},{"strategyName":"Magic Formula: Value + Qualität","strategySlug":"qualitaet-value"},{"strategyName":"Unterbewertete Aktien: Mehrfaktor-Check","strategySlug":"unterbewertung-mehrfaktor"},{"strategyName":"Defensiv: Low Volatility","strategySlug":"defensiv-low-volatility"},{"strategyName":"PEG-Strategie nach Peter Lynch","strategySlug":"peg-strategie"},{"strategyName":"Dividenden-Aristokraten & Kontinuität","strategySlug":"dividenden-kontinuitaet"},{"strategyName":"Acquirer's Multiple: EV/EBIT Deep Value","strategySlug":"ev-ebit-deep-value"},{"strategyName":"High-Growth / Rule of 40","strategySlug":"high-growth-rule-of-40"}],"company":{"description":"Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.","industry":"Drug Manufacturers - General","ipoDate":"1978-01-13"},"sectorBreakdown":{"growth":{"metrics":[{"counts":true,"field":"revenue_growth","lowerIsBetter":false,"rank":15.6,"sectorMedian":8.039862019201006,"value":1.1812741553422157},{"counts":true,"field":"earnings_growth_3y","lowerIsBetter":false,"rank":56.2,"sectorMedian":5.440658922332009,"value":8.429515633293082},{"counts":true,"field":"earnings_growth_5y","lowerIsBetter":false,"rank":85.3,"sectorMedian":7.003389122494063,"value":21.225687893971056},{"counts":true,"field":"sus_growth","lowerIsBetter":false,"rank":78.3,"sectorMedian":3.6635701466492088,"value":6.333364137633614}],"value":58.8},"momentum":{"metrics":[{"counts":true,"field":"one_yr","lowerIsBetter":false,"rank":91.7,"sectorMedian":8.663206112670974,"value":61.44744711475716},{"counts":true,"field":"six_m","lowerIsBetter":false,"rank":70.1,"sectorMedian":24.27032259851255,"value":32.221646522115044},{"counts":true,"field":"three_m","lowerIsBetter":false,"rank":62.9,"sectorMedian":15.416211475410979,"value":19.24709826047387},{"counts":true,"field":"pct_from_52w_high","lowerIsBetter":false,"rank":54.3,"sectorMedian":-7.345407316545205,"value":-6.21284755512943}],"value":69.8},"profitability":{"metrics":[{"counts":true,"field":"roe","lowerIsBetter":false,"rank":88.1,"sectorMedian":11.52412853150564,"value":34.69946393947458},{"counts":true,"field":"roc_greenblatt","lowerIsBetter":false,"rank":74.3,"sectorMedian":32.54750002450021,"value":55.90307531181568},{"counts":true,"field":"ebit_margin","lowerIsBetter":false,"rank":91.5,"sectorMedian":18.305086092796074,"value":36.173489819178755},{"counts":true,"field":"fcf_margin","lowerIsBetter":false,"rank":67.3,"sectorMedian":14.117834756719867,"value":19.037057573237224},{"counts":true,"field":"gross_margin","lowerIsBetter":false,"rank":73.2,"sectorMedian":60.99422024571629,"value":71.97578781997966}],"value":78.9},"quality":{"metrics":[{"counts":true,"field":"sloan_ratio","lowerIsBetter":true,"rank":9,"sectorMedian":0.2985136689791994,"value":12.22418219331265},{"counts":true,"field":"share_change","lowerIsBetter":true,"rank":71.6,"sectorMedian":-0.002392665312306813,"value":-1.338055883510429},{"counts":true,"field":"dividend_streak_years","lowerIsBetter":false,"rank":85.9,"sectorMedian":10,"value":21},{"counts":true,"field":"reaction_rel","lowerIsBetter":false,"rank":79.5,"sectorMedian":0.05056951189927883,"value":3.8797502400232386}],"value":61.5},"risk":{"metrics":[{"counts":true,"field":"equity_ratio","lowerIsBetter":false,"rank":28.4,"sectorMedian":48.4008953898299,"value":38.43613461341751},{"counts":true,"field":"debt_to_ebitda","lowerIsBetter":true,"rank":44.7,"sectorMedian":1.1117596945697787,"value":1.2726983228363173},{"counts":true,"field":"dte","lowerIsBetter":true,"rank":22.6,"sectorMedian":0.4838372886800787,"value":0.9606128578489146},{"counts":true,"field":"volatility_1y","lowerIsBetter":true,"rank":60.1,"sectorMedian":31.42353880746313,"value":30.13249579090496}],"value":38.9},"valuation":{"metrics":[{"counts":true,"field":"earnings_yield","lowerIsBetter":false,"rank":79.5,"sectorMedian":2.8966594312400864,"value":4.962320319434895},{"counts":true,"field":"fcf_yield","lowerIsBetter":false,"rank":44.2,"sectorMedian":3.629326385869834,"value":3.387799785103739},{"counts":true,"field":"ev_to_sales","lowerIsBetter":true,"rank":33,"sectorMedian":4.026437265234489,"value":6.173298238410118},{"counts":true,"field":"ev_ebit","lowerIsBetter":true,"rank":70.9,"sectorMedian":21.726364951966808,"value":17.065807775994863}],"value":56.9}},"expectation":{"inputs":{"basis":"fcf","capex":null,"capexDepressed":false,"fcf":12360000000,"fcfBasis":"fy","fcfNormalized":null,"fcfWindowEnd":null,"fcfYear":2025,"kbv":6.992588488005171,"marketCap":364838561427.0153,"marks":{"fiveYear":9.77,"tenYear":6.14}},"standard":{"basis":"fcf","case":"aboveMarks","discountRate":9,"noGrowthValue":137333333333.33334,"value":13.636445011297837,"years":10},"standardNormalized":null},"quarterChanges":{"case":"mixed","changes":[{"change":13.8,"current":16063000000,"direction":"better","metric":"fcf","previous":14115000000,"signChange":false,"unit":"percent"},{"change":-10.94,"current":16.65,"direction":"worse","metric":"ebitMargin","previous":27.59,"signChange":false,"unit":"pp"},{"change":2.67,"current":24.19,"direction":"better","metric":"fcfMargin","previous":21.52,"signChange":false,"unit":"pp"},{"change":-11.91,"current":7.57,"direction":"worse","metric":"roe","previous":19.48,"signChange":false,"unit":"pp"}],"current":{"quarter":2,"year":2026},"previous":{"quarter":1,"year":2026},"unchanged":["revenue","grossMargin","netDebt","sharesOutstanding"]},"evidence":{"anomalies":[],"contra":["expectationAboveHistory"],"moat":[{"holds":false,"key":"stableGrossMargin","median":69.96,"spread":11.57,"years":10},{"first":72.02,"holds":false,"key":"risingGrossMargin","last":71.98,"years":5},{"holds":false,"key":"highReturnOnCapital","min":3.65,"years":10},{"holds":false,"key":"lowCapitalIntensity","median":6.38,"years":10},{"holds":false,"key":"steadyFcfMargin","min":11.37,"spread":16.83,"years":10}],"phase":{"ebitMargin":36.2,"financingCf":-1922000000,"investingCf":-13741000000,"key":"payout","operatingCf":16472000000,"payoutShare":82.2,"revenueCagr3y":3.1,"revenueGrowthYoy":null},"pro":[]},"valuationBand":{"anchor":{"quarter":2,"year":2026},"high":16.8,"low":12.2,"median":15,"metric":"priceToOcf","multiple":18.2,"position":"above","priceAsOf":"2026-11-06","quarters":20}}